Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
Replimune Inc.
Aulos Bioscience, Inc.
Abramson Cancer Center at Penn Medicine
Melanoma Institute Australia
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc.
University of Arizona
Melanoma Institute Australia
Memgen, Inc.
University of Pittsburgh
Marengo Therapeutics, Inc.
UNICANCER
AdventHealth Translational Research Institute
Weill Medical College of Cornell University
Melanoma and Skin Cancer Trials Limited